Organization: Canacord Capital Corp

Labopharm raises $22 million for product launch and R&D

Labopharm Inc is set to complete a $22-million share issue on July 15 to support the commercial launch of its tramadol analgesic and advance development of a new program in the Laval PQ-based firm’s pipeline. The financing is a bought deal by a syndicate of underwriters led by National Bank Financial Inc and including RBC…